AVIPERO

General Information

Company Name

AVIPERO

Founded Year

2023

Location (Offices)

Wilmington, United States +1

Founders / Decision Makers

Number of Employees

Industries

Health Care, Pharmaceutical

Funding Stage

Social Media

AVIPERO - Company Profile

AVIPERO is a health care and pharmaceutical startup that specializes in the development of unique allosteric modulators of integrins for tissue repair and age-related diseases. Founded in 2023, AVIPERO aims to revolutionize the field of medicine by focusing on innovative solutions for age-related ailments. As a potential investment opportunity, AVIPERO presents an intriguing prospect within the health care and pharmaceutical industries. With its pioneering approach, the company has the potential to make significant contributions to the future of healthcare.

Taxonomy: Drug Development, Integrin, Tissue Repair, Regenerative Medicine, Allosteric Modulator, COPD, Arthritis, Parkinson's Disease, Metastatic Breast Cancer, Cancer, Age-Related Diseases

Funding Rounds & Investors of AVIPERO (0)

View All

There is no investment information

Latest News of AVIPERO

View All

No recent news or press coverage available for AVIPERO .

Similar Companies to AVIPERO

View All

Dana-Farber Cancer Institute

Umoja Biopharma Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengineering immune cells directly within the patient.

Alethia Biotherapeutics Inc. Immunotherapeutics against disease-specific targets

Carcidiag Biotechnologies French startup Carcidiag offers innovative cancer detection tool from Guéret, France.

Michiana Hematology Oncology (MHO) Bringing world-class cancer care to northern Indiana

AVIPERO - Company Profile

Funding Rounds & Investors of AVIPERO (0)

Latest News of AVIPERO

Similar Companies to AVIPERO

Want to dive deeper into AVIPERO ? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.